Trexquant Investment LP Halozyme Therapeutics, Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$37.81 - $52.4 $556,185 - $770,804	14,710 Added 17.23%	100,076 $5.24 Million
Q1 2024 May 14, 2024	SELL	$33.68 - $41.95 $1.15 Million - $1.44 Million	-34,218 Reduced 28.61%	85,366 $3.47 Million
Q4 2023 Feb 09, 2024	BUY	$33.32 - $42.1 $163,967 - $207,174	4,921 Added 4.29%	119,584 $4.42 Million
Q3 2023 Nov 13, 2023	BUY	$36.46 - $44.03 $483,386 - $583,749	13,258 Added 13.07%	114,663 $4.38 Million
Q2 2023 Aug 11, 2023	BUY	$30.28 - $38.74 $1.12 Million - $1.43 Million	36,937 Added 57.3%	101,405 $3.66 Million
Q1 2023 May 15, 2023	BUY	$32.86 - $55.7 $2.12 Million - $3.59 Million	64,468 New	64,468 $2.46 Million
Q2 2022 Aug 11, 2022	SELL	$37.35 - $48.3 $278,332 - $359,931	-7,452 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$31.97 - $41.06 $411,741 - $528,811	-12,879 Reduced 63.35%	7,452 $297,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $488,946 - $626,164	15,366 Added 309.49%	20,331 $818,000
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $674,725 - $814,160	-17,539 Reduced 77.94%	4,965 $202,000
Q2 2021 Aug 12, 2021	BUY	$38.84 - $51.31 $129,376 - $170,913	3,331 Added 17.37%	22,504 $1.02 Million
Q1 2021 May 13, 2021	BUY	$39.51 - $51.45 $757,525 - $986,450	19,173 New	19,173 $799,000
Q4 2020 Feb 11, 2021	SELL	$25.81 - $43.62 $794,793 - $1.34 Million	-30,794 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$25.74 - $29.63 $325,508 - $374,700	-12,646 Reduced 29.11%	30,794 $809,000
Q2 2020 Aug 07, 2020	SELL	$16.25 - $26.81 $261,267 - $431,051	-16,078 Reduced 27.01%	43,440 $1.17 Million
Q1 2020 May 08, 2020	SELL	$13.9 - $21.83 $668,965 - $1.05 Million	-48,127 Reduced 44.71%	59,518 $1.07 Million
Q4 2019 Feb 12, 2020	BUY	$14.93 - $19.53 $1.61 Million - $2.1 Million	107,645 New	107,645 $1.91 Million
Q4 2018 Feb 13, 2019	SELL	$13.33 - $18.66 $151,922 - $212,668	-11,397 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$16.68 - $18.41 $190,101 - $209,818	11,397 New	11,397 $207,000
Q2 2018 Aug 07, 2018	SELL	$16.87 - $20.3 $211,870 - $254,947	-12,559 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$17.06 - $21.2 $214,256 - $266,250	12,559 New	12,559 $246,000
Q4 2017 Feb 09, 2018	SELL	$16.75 - $20.8 $216,326 - $268,632	-12,915 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$11.76 - $17.4 $151,880 - $224,720	12,915	12,915 $224,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account